Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00571285 · ClinicalTrials.gov registry record · Phase 4
Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease
A Phase 4 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT00571285 is a Phase 4 study that was terminated before completion, run by Emory University. The registered enrollment target is 31 participants.
The verdict
NCT00571285, a Phase 4 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
Retrospective review of records in the Emory Movement Disorders clinic suggests vitamin D deficiency occurs in over 80% of patients with Parkinson's Disease (PD), much more frequently than in internal medicine clinics. Laboratory studies have suggested vitamin D could play a role in the development of PD. In addition, low vitamin D levels have been associated with slower walking speeds, worse memory and thinking, and depression.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Vitamin D3
- DIETARY_SUPPLEMENT Vitamin D3 - high dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2007-06 |
| Est. Completion | 2015-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00571285
The ClinicalTrials.gov registry entry for NCT00571285 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00571285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00571285 about?
NCT00571285 is a clinical study titled "Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease". Retrospective review of records in the Emory Movement Disorders clinic suggests vitamin D deficiency occurs in over 80% of patients with Parkinson's Disease (PD), much more frequently than in internal medicine clinics. Laboratory studies have suggested vitamin D could play a role in the development ...
What is the current status of trial NCT00571285?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2007-06. Estimated completion is 2015-09.
What interventions are being tested in trial NCT00571285?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin D3 (DIETARY_SUPPLEMENT), Vitamin D3 - high dose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00571285?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.